Ashwini Nadkarni, MD
Disclosures
Nadkarni reports no relevant financial disclosures.
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
One important evidence base that is accumulating is actually digital therapeutics. So for instance, prescription-specific, FDA-approved cognitive behavioral therapy smartphone applications. These have accumulated evidence for their use. And these have been shown to be, superior to modalities like psychoeducation. So I think that those are actually, like, fantastic, treatment options for patients who may not necessarily have access to medical care.
